Little Green Pharma locks in major sales agreement with German cannabis company

Australian medical cannabis company Little Green Pharma (ASX: LGP) has reached a major offtake agreement with Demecan to distribute cannabis products across Germany. With the German medical cannabis market estimated to be worth €7.7bn (A$11.2bn) by 2028, this opportunity marks a massive milestone for the Company. In July 2021, LGP acquired a world-class cultivation site … Read more